| Favourites |

FAQ

General

Assigned items: 2

Paid Subscription

Assigned items: 4

Free Subscription

Assigned items: 2

News Letter

Assigned items: 2

Newsletter

BioMedReports Athersys, Inc. (NASDAQ:ATHX) plunges 40% after stem cell therapy flunks Phase II stroke trial: In-development ... http://t.co/NrhUjWp4EY
3hreplyretweetfavorite
BioMedReports Momenta Spikes Up Following FDA News On Copaxone; StemCells Completes Enrollment of canada pharmacy First Cohort in Phase II P... http://t.co/sJOYmzcgO8
BioMedReports FDA gives Fast Track Designation for MediciNova, Inc. (NASDAQ:MNOV)’s MN-001, Shares Up 45%: Shares of viagra original pfizer order Medici... http://t.co/hHPqfSkm81